Bifocal Tuberculosis with Adalimumab Revealed by Laryngeal Involvement: Case Report
Open Access
- 1 March 2021
- journal article
- research article
- Published by Ivano-Frankivsk National Medical University in Galician Medical Journal
- Vol. 28 (1) , E202117
Abstract
Introduction. Anti-TNF treatment has transformed the treatment of chronic inflammatory rheumatism. Although the therapy can be highly effective, anti-TNF drugs are associated with an increased risk of tuberculosis, especially extra-pulmonary tuberculosis. Laryngeal tuberculosis is rare and its symptoms are not specific. Laryngeal tuberculosis is often secondary to another localization, particularly pulmonary. In the use of anti-TNF therapy, its development is unusual. Case report. We report a case of bifocal tuberculosis: laryngeal and pulmonary tuberculosis revealed by laryngeal involvement in a patient aged 41 years with axial spondylarthritis treated with Adalimumab. Conclusion. This presentation highlights the importance to consider the rare possibility of laryngeal tuberculosis in the presence of atypical otorhinolaryngologic signs under anti-TNF therapy and underlines the importance of looking for other tuberculosis involvement.Keywords
This publication has 19 references indexed in Scilit:
- Miliary tuberculosis: A new look at an old foeJournal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2016
- Secondary laryngeal tuberculosis revisitedLung India, 2015
- Laryngeal tuberculosis in the United States of America: A forgotten diseaseScandinavian Journal of Infectious Diseases, 2014
- Tuberculosis in anti-TNF-α treated patients remains a problem in countries with an intermediate incidence: Analysis of 25 patients matched with a control populationJournal of Crohn's and Colitis, 2013
- Risk of developing tuberculosis under anti-TNF treatment despite latent infection screeningJournal of Crohn's and Colitis, 2013
- Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three‐year prospective french research axed on tolerance of biotherapies registryArthritis & Rheumatism, 2009
- Laryngeal involvement in patients with active pulmonary tuberculosis2007
- Current clinical propensity of laryngeal tuberculosis: review of 60 casesEuropean Archives of Oto-Rhino-Laryngology, 2006
- BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF- treatmentThorax, 2005
- Laryngeal tuberculosis: an important diagnosisThe Journal of Laryngology & Otology, 2000